Mycobacterial infections: basic research visits
clinical experience and vice-versa
Sunday, October 8, 2006
18h00
Welcome and introductory remarks
By Jean-Claude Piffaretti
18h15
Opening lecture
Global epidemiology of tuberculosis: an overview
Christofer Dye (WHO, Geneva)
19h15
Dinner
Monday, October 9, 2006
Genomic and Pathogenesis
Chairpersons: B. Gicquel, J. Pieters
08h30
Host pathogen interactions during infection by Mycobacterium tuberculosis
Brigitte Gicquel (F-Paris)
09h30
Signaling pathways involved in the survival of pathogenic mycobacteria
Jean Pieters (CH-Basel)
10h30
Coffee break
11h00
Monitoring and modulating mycobacterium-host interactions in real-time in transparent zebrafish embryos
Lalita Ramakrishnan (USA-Seattle)
12h00
Antimicrobial peptides in immunity to tuberculosis
Stefen Stenger (G-Erlangen)
13h00
Lunch
14h30
Oral presentations and Posters: genomic and pathogenesis
(16) Buroni Silvia: LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis
(23) Abdallah Abdallah Musa: A specific secretion system mediates PPE41 transport in pathogenic Mycobacteria
(19) Rosas Samantha.: High clustering rate in Multidrugresistant Mycobacterium tuberculosis isolates by Double Repetitive element PCR in Panama.
(12) Silzen Veronika.: Molecular Genetic Analysis of Nucleotide Polymorphisms Associated with Izoniazid Resistance in Mycobacterium tuberculosis Isolated in Belarus
(10) Zaker Saeed.: Molecular Characterization of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated from patients with tuberculosis in Iran
(15) Zaker Saeed. : Molecular Characterization of Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates in Iran by sequencing
Tuesday, October 10, 2006
Epidemiology and Prevention
Chairpersons: D. Garcia de Viedma, G. Rook
New epidemiological and clinical features revealed by the clonal analysis of the infection by M. tuberculosis
Dario Garcia de Viedma (S-Madrid)
Single-nucleotide polymorphism-based population genetic analysis of
Mycobacterium tuberculosis strains from 4 geographic sites
Gutacker Michaela(CH-Bellinzona)
Tuberculosis in rich and developing countries: epidemiology meets immunology
Graham Rook (UK-London)
Prospects for vaccines and immunotherapies for TB
Douglas B. Lowrie (UK-Cardiff)
14h00
Excursion
Wednesday, October 11, 2006
Clinical aspects, Antimicrobial resistance and Treatment
Chairpersons: F. Portaels, L. Fattorini
Mycobacterium ulcerans: pathogenesis, diagnosis, control, and treatment
Françoise Portaels (B-Antwerpen)
The present situation of drug resistant TB in the world and the role of mycobacterial efflux transporters
José A. Aínsa(S-Zaragoz) and Giovanna Riccardi (I-Pavia)
New drugs for the treatment of mycobacterial diseases: an overview
Christian Lienhardt (F-Paris)
Diarylquinolines may offer new opportunities to treat mycobacterial diseases
Koen Andries (B-Beerse)
Animal models for the study of antimycobacterial drugs
Lanfranco Fattorini (I-Rome)
Oral presentations and Posters: epidemiology, prevention and treatment
(8) Druszczynska Magdalena.: The balance between Th1 and Th2 immune responses in healthy individuals vaccinated with BCG and DTP
(7) Strapagiel Dominik.: CD14 and TLR4 receptors in delayed type hypersensitivity to PPD in young healthy volunteers vaccinated with Mycobacterium bovis BCG
(17) McGowan Edward.: Mycobacterial Hsp70 and Dendritic Cells
(22) VandenWijngaert Sigi.: Prospective Evaluation of Selection Criteria for the Use of Nucleic Acid Amplification Techniques to Test for the Presence of Mycobacterium tubercul
Closing lecture
Improving tuberculosis control
19h00
Concluding remarks
End of the conference
19h30
Thursday, October 12, 2006
07h45 Bus departure in front of the hotel
